American Capital Advisory’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
American Capital Advisory's BSX Position: Q2 2026 in Review
American Capital Advisory reduced its Boston Scientific (BSX) stake by 35% in Q2 2026, selling an estimated $1.03K and leaving 36 shares worth $1.54K. The position accounts for ﹤0.01% of the portfolio, ranked #688.
American Capital Advisory first reported a position in BSX in Q2 2025 and has held it in 5 quarters since. The position peaked at $4.94K in Q2 2025. 1,478 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- American Capital Advisory held 36 shares of Boston Scientific worth $1.54K as of Q2 2026.
- American Capital Advisory sold 19 Boston Scientific shares in Q2 2026, an estimated $1.03K.
- Boston Scientific made up ﹤0.01% of American Capital Advisory's portfolio in Q2 2026, its #688 holding.
- American Capital Advisory first reported a position in Boston Scientific in Q2 2025 and has held it in 5 quarters since.
- American Capital Advisory's Boston Scientific position peaked at $4.94K in Q2 2025.
- 1,478 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on American Capital Advisory's 13F filing for Q2 2026, filed 28 Jul 2026.